| | 166518-60-1 Basic information More.. |
| Product Name: | Avasimibe | | Synonyms: | Avasimibe, >=98%;2,6-diisopropylphenyl 2-(2,4,6-triisopropylphenyl)acetylsulfamate;[[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 2,6-bis(1-methylethyl)phenyl ester] sulfamic acid;PD 148515;avasimibe;n-(2,6-dipropan-2-ylphenoxy)sulfonyl-2-(2,4,6-tripropan-2-ylphenyl)acetamide;N-[(2,6-DIISOPROPYLPHENOXY)SULFONYL]-2-(2,4,6-TRIISOPROPYLPHENYL)ACETAMIDE;((2,4,6-TRIS(1-METHYLETHYL)PHENYL)ACETYL)SULFAMICACID2,6-BIS(1-METHYLETHYL)PHENYLESTER | | CAS: | 166518-60-1 | | MF: | C29H43NO4S | | MW: | 501.72 | | EINECS: | 1592732-453-0 | | Mol File: | 166518-60-1.mol |  |
Use
Avasimibe is a selective inhibitor of Cholesterol Acyltransferase 1 and CYP2C9. Avasimibe is known to induce apoptosis of glioma cell lines as a model of glioblastoma.
- Avasimibe
-
- US $43.00-148.00 / mg
- 2024-11-19
- CAS:166518-60-1
- Min. Order:
- Purity: 99.91%
- Supply Ability: 10g
- Avasimibe
-
- US $1.00 / g
- 2019-12-20
- CAS:166518-60-1
- Min. Order: 200KG
- Purity: 99%
- Supply Ability: 2tons
|
|
166518-60-1
Recommend Suppliers |
|